National Bank Of Canada Neuronetics, Inc. Transaction History
National Bank Of Canada
- $73.7 Billion
- Q4 2024
A detailed history of National Bank Of Canada transactions in Neuronetics, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 59 shares of STIM stock, worth $262. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59Holding current value
$262% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding STIM
# of Institutions
48Shares Held
10MCall Options Held
24.1KPut Options Held
200-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$7.73 Million1.44% of portfolio
-
Masters Capital Management LLC Atlanta, GA1.5MShares$6.68 Million0.08% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.48MShares$6.59 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.28MShares$5.7 Million0.0% of portfolio
-
Four World Capital Management LLC New York, NY858KShares$3.82 Million0.69% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $120M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...